BCV
DGX icon

Banque Cantonale Vaudoise’s Quest Diagnostics DGX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372 Sell
1,756
-6
-0.3% -$1.18K ﹤0.01% 564
2026
Q1 		$346K Sell
1,762
-5,219
-75% -$1.01M 0.01% 555
2025
Q4 		$1.21M Sell
6,981
-8,241
-54% -$1.5M 0.04% 344
2025
Q3 		$2.9M Buy
15,222
+5,985
+65% +$1.06M 0.11% 182
2025
Q2 		$1.66M Buy
9,237
+383
+4% +$66.5K 0.07% 277
2025
Q1 		$1.5M Buy
+8,854
New +$1.45M 0.07% 284
2024
Q3 		$3.33M Sell
21,482
-8,627
-29% -$1.29M 0.14% 170
2024
Q2 		$4.12M Buy
30,109
+8,087
+37% +$1.11M 0.16% 113
2024
Q1 		$2.93M Buy
22,022
+1,423
+7% +$185K 0.11% 186
2023
Q4 		$2.84M Buy
20,599
+7,150
+53% +$940K 0.12% 174
2023
Q3 		$1.64M Sell
13,449
-1,717
-11% -$229K 0.08% 201
2023
Q2 		$2.13M Sell
15,166
-16,947
-53% -$2.34M 0.1% 178
2023
Q1 		$4.54M Buy
32,113
+1,817
+6% +$260K 0.22% 94
2022
Q4 		$4.74M Buy
30,296
+7,680
+34% +$1.1M 0.25% 85
2022
Q3 		$2.78M Sell
22,616
-6
-0% -$790 0.16% 118
2022
Q2 		$3.01M Buy
22,622
+9,552
+73% +$1.3M 0.16% 124
2022
Q1 		$1.79M Sell
13,070
-9,352
-42% -$1.3M 0.08% 254
2021
Q4 		$3.88M Buy
22,422
+454
+2% +$69.1K 0.15% 131
2021
Q3 		$3.19M Sell
21,968
-462
-2% -$67.6K 0.14% 143
2021
Q2 		$2.96M Buy
22,430
+11,884
+113% +$1.56M 0.13% 165
2021
Q1 		$1.35M Sell
10,546
-31
-0.3% -$3.82K 0.07% 293
2020
Q4 		$1.26M Buy
10,577
+5,278
+100% +$643K 0.07% 248
2020
Q3 		$607K Sell
5,299
-7,400
-58% -$874K 0.04% 385
2020
Q2 		$1.45M Sell
12,699
-2,700
-18% -$286K 0.11% 191
2020
Q1 		$1.24M Buy
15,399
+9,100
+144% +$942K 0.1% 199
2019
Q4 		$673K Buy
+6,299
New +$657K 0.05% 374

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Banque Cantonale Vaudoise's DGX Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its Quest Diagnostics (DGX) stake by 0.34% in Q2 2026, selling an estimated $1.18K and leaving 1,756 shares worth $372. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Banque Cantonale Vaudoise first reported a position in DGX in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.74M in Q4 2022. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Banque Cantonale Vaudoise held 1,756 shares of Quest Diagnostics worth $372 as of Q2 2026.
  • Banque Cantonale Vaudoise sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #564 holding.
  • Banque Cantonale Vaudoise first reported a position in Quest Diagnostics in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's Quest Diagnostics position peaked at $4.74M in Q4 2022.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.